Mursla Bio partners with global pharma to advance precision medicine in liver disease - PharmaTimes AI platform to support biomarker-guided therapy development in MASH

#hepatology #MurslaBio #precisionmedicine #liverdisease #biomarkerguidedtherapydevelopment #MASH #metabolicdysfunctionassociatedsteatohepatitis #AIPrecisionMedicinePlatform #MEV01clinicalstudy #EvoLiver #biomarkerguidedprecisionmedicine #livercare #fattyliverdisease
zurl.co/ZCOOD